Your early-stage program is moving at orbital speed. Your CDMO should too.
Early-stage small molecule development is a race against time. Tight clinical timelines, evolving processes, limited resources, and increasing regulatory expectations leave little room for delay.
At Axplora, we’ve built an early-phase offering designed to help innovators accelerate their path to the clinic.
With over 15 years of experience, dedicated assets, specialized technologies, and the ability to deliver first GMP kilograms in less than 6 months, we help transform development challenges into launch-ready milestones.
Discover how Axplora can help de-risk development and accelerate your journey!
Access gated content
Fill the form below to access this resource.
Related resources
Brochure
Axplora’s bet on next gen therapeutics
Learn more about Axplora’s recent series of strategic investments! As biopharma pipelines shift toward more complex and targeted therapies, expectations are rising. It’s no longer just about capacity or cost. Today, companies are looking for partners who can anticipate needs, manage complexity, and accelerate the path to patients. Recent industry coverage, including 247 Biopharma, highlights […]
Brochure
Charting a course for peptide therapeutic purification success
Purifying peptide APIs isn’t just a step. It’s a science of manufacturing. So, how can pharmaceutical companies overcome specific hurdles of peptide manufacturing, pairing upstream process strategies with robust downstream processing? At Axplora, we’ve built our name, through our heritage, solving the hardest purification challenges with speed, reliability, and imaginative precision. From lab to large-scale, we turn complexity […]
Brochure
Products portfolio
At Axplora, we honor ourselves on providing an extensive and diverse portfolio of small molecule Active Pharmaceutical Ingredients (APIs) that cater to the evolving needs of the pharmaceutical industry. As a prominent figure in the global pharmaceutical landscape, we have established ourselves as a leading manufacturer, specializing in both non-sterile and sterile steroids.
We enable our partners to fully realize their ambitions.
Driven by the curiosity, skills and dedication of over 2,000 employees on three continents, Axplora delivers sustainable, technologically advanced API solutions to improve lives worldwide.